{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:14:30Z","timestamp":1792620870069,"version":"4.5.0"},"reference-count":40,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Regional Citrate Anticoagulation (RCA) is considered the first-line anticoagulation for Continuous Kidney Replacement Therapy (CKRT). The RCA requires strict protocols and trained staff to avoid unsafe use and ensure its benefit. We have analyzed all our CKRT prescriptions from December 2020 to April 2022 anonymously, collecting data on CKRT, lab tests, clinical conditions, and complications of RCA. In addition, in order to better detect citrate accumulation, we have performed an RCA protocol by reducing the CaTot\/Ca2+ ratio cut-off from 2.50 to 2.40 and increasing the number of calcium checks according to its trend. Among the 374 patients in CKRT, 104 received RCA prescriptions, of which 11 (10.6%) were discontinued: 4 for the suspicion of citrate accumulation, 1 for the development of metabolic alkalosis, 1 for the shift to a different CKRT procedure due to the need for a higher bicarbonate dose, 4 for the elevation of hepatocytolysis indexes, and 1 due to a preemptive discontinuation following massive post-surgery bleeding. None of the patients have had citrate toxicity as indicated by a CaTot\/Ca2+ greater than 2.50, and our protocol has allowed the early identification of patients who might develop clinical citrate toxicity.<\/jats:p>","DOI":"10.3390\/jcm12165201","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T10:52:40Z","timestamp":1691664760000},"page":"5201","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety of Citrate Anticoagulation in CKRT: Monocentric Experience of a Dynamic Protocol of Calcium Monitoring"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-2764","authenticated-orcid":false,"given":"Federico","family":"Nalesso","sequence":"first","affiliation":[{"name":"Department of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bettin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bogo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-1362","authenticated-orcid":false,"given":"Martina","family":"Cacciapuoti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Cattarin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Scaparrotta","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7534-0128","authenticated-orcid":false,"given":"Lorenzo A.","family":"Cal\u00f2","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","article-title":"Continuous renal replacement therapy: A worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators","volume":"33","author":"Uchino","year":"2007","journal-title":"Intensive Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000468833","article-title":"Citrate Anticoagulation during Continuous Renal Replacement Therapy","volume":"190","author":"Ricci","year":"2017","journal-title":"Contrib. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/cc5937","article-title":"Clinical review: Patency of the circuit in continuous renal replacement therapy","volume":"11","author":"Joannidis","year":"2007","journal-title":"Crit. Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2020.18618","article-title":"Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial","volume":"324","author":"Zarbock","year":"2020","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-015-0822-z","article-title":"Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: A randomized controlled trial","volume":"19","author":"Stucker","year":"2015","journal-title":"Crit. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/CCM.0000000000001004","article-title":"A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults","volume":"43","author":"Gattas","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s13054-014-0472-6","article-title":"Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: A multi-center randomized clinical trial","volume":"18","author":"Schilder","year":"2014","journal-title":"Crit. Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00134-011-2438-3","article-title":"Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy","volume":"38","author":"Zhang","year":"2012","journal-title":"Intensive Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","article-title":"Citrate versus heparin anticoagulation for continuous renal replacement therapy: An updated meta-analysis of RCTs","volume":"41","author":"Bai","year":"2015","journal-title":"Intensive Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13054-016-1299-0","article-title":"Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis with trial sequential analysis of randomized controlled trials","volume":"20","author":"Liu","year":"2016","journal-title":"Crit. Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5603\/CJ.a2020.0039","article-title":"Filter life span in postoperative cardiovascular surgery patients requiring continuous renal replacement therapy, using a postdilution regional citrate anticoagulation continuous hemofiltration circuit","volume":"29","author":"Kirwan","year":"2022","journal-title":"Cardiol. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2478\/jtim-2018-0026","article-title":"Citrate: How to Get Started and What, When, and How to Monitor?","volume":"6","author":"Honore","year":"2018","journal-title":"J. Transl. Int. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.jvca.2004.07.016","article-title":"Dose-response relationship between plasma ionized calcium concentration and thrombelastography","volume":"18","author":"James","year":"2004","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000046075","article-title":"Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation","volume":"89","author":"Calatzis","year":"2001","journal-title":"Nephron"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00003246-200104000-00010","article-title":"Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation","volume":"29","author":"Gitomer","year":"2001","journal-title":"Crit. Care Med."},{"key":"ref_16","first-page":"42","article-title":"Proactive approach for the patient safety in the extracorporeal blood purification treatments in nephrology","volume":"35","author":"Nalesso","year":"2018","journal-title":"G. Ital. Di Nefrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1159\/000513150","article-title":"Measurement of the Concentration of Citrate in Human Biofluids in Patients Undergoing Continuous Renal Replacement Therapy Using Regional Citrate Anticoagulation: Application of a Two-Step Enzymatic Assay","volume":"50","author":"Anstey","year":"2021","journal-title":"Blood Purif."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1159\/000524129","article-title":"A Comparison of the Commonly Used Surrogate Markers for Citrate Accumulation and Toxicity during Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation","volume":"51","author":"Anstey","year":"2022","journal-title":"Blood Purif."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/cc11363","article-title":"Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients","volume":"16","author":"Link","year":"2012","journal-title":"Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13613-020-0648-y","article-title":"Prescription of CRRT: A pathway to optimize therapy","volume":"10","author":"Karkar","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"R162","DOI":"10.1186\/cc11485","article-title":"Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: A prospective observational study","volume":"16","author":"Saugel","year":"2012","journal-title":"Crit. Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13054-015-1066-7","article-title":"Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: The Liver Citrate Anticoagulation Threshold (L-CAT) observational study","volume":"19","author":"Slowinski","year":"2015","journal-title":"Crit. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/1744-9987.12280","article-title":"Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction","volume":"19","author":"Messino","year":"2015","journal-title":"Ther. Apher. Dial."},{"key":"ref_24","first-page":"202","article-title":"Clinical review: Anticoagulation for continuous renal replacement therapy--heparin or citrate?","volume":"15","author":"Kellum","year":"2011","journal-title":"Crit. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.34067\/KID.0005342020","article-title":"Regional Citrate Anticoagulation Protocol for Patients with Presumed Absent Citrate Metabolism","volume":"2","author":"Szamosfalvi","year":"2021","journal-title":"Kidney360"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Morabito, S., Pistolesi, V., Tritapepe, L., Vitaliano, E., Zeppilli, L., Polistena, F., Fiaccadori, E., and Pierucci, A. (2013). Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: Effects on acid-base status and phosphate supplementation needs. BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-232"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.ajkd.2021.01.017","article-title":"Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study","volume":"78","author":"Rhee","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/MCC.0000000000000547","article-title":"Regional citrate anticoagulation for continuous renal replacement therapy","volume":"24","author":"Brandenburger","year":"2018","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/IJNRD.S198222","article-title":"Evaluating Nephrocheck((R)) as a Predictive Tool for Acute Kidney Injury","volume":"13","author":"Nalesso","year":"2020","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000485591","article-title":"Predicting Acute Kidney Injury in Intensive Care Unit Patients: The Role of Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein-7 Biomarkers","volume":"45","author":"Nalesso","year":"2018","journal-title":"Blood Purif."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jcrc.2007.12.017","article-title":"Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury","volume":"24","author":"Bagshaw","year":"2009","journal-title":"J. Crit. Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.mayocp.2021.07.001","article-title":"Acute Kidney Injury in Severe COVID-19 Has Similarities to Sepsis-Associated Kidney Injury: A Multi-Omics Study","volume":"96","author":"Alexander","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit. Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13054-016-1489-9","article-title":"Nomenclature for renal replacement therapy in acute kidney injury: Basic principles","volume":"20","author":"Neri","year":"2016","journal-title":"Crit. Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13054-017-1880-1","article-title":"Complications of regional citrate anticoagulation: Accumulation or overload?","volume":"21","author":"Schneider","year":"2017","journal-title":"Crit. Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s44158-023-00091-w","article-title":"Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): Expert opinion from the SIAARTI-SIN joint commission","volume":"3","author":"Pistolesi","year":"2023","journal-title":"J. Anesth. Analg. Crit. Care"},{"key":"ref_37","first-page":"544","article-title":"Implementing the Kidney Disease: Improving Global Outcomes\/acute kidney injury guidelines in ICU patients","volume":"19","author":"Hoste","year":"2013","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Guo, L., Hu, Y., Zeng, Q., and Yang, X. (2023). Factors affecting continuous renal replacement therapy duration in critically ill patients: A retrospective study. Ther. Apher. Dial.","DOI":"10.1111\/1744-9987.14024"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2215\/CJN.01280214","article-title":"Regional citrate anticoagulation for RRTs in critically ill patients with AKI","volume":"9","author":"Morabito","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"154364","DOI":"10.1016\/j.jcrc.2023.154364","article-title":"Impact of increasing post-filter ionized calcium target on filter lifespan in renal replacement therapy with regional citrate anticoagulation: A before-and-after study","volume":"78","author":"Assefi","year":"2023","journal-title":"J. Crit. Care"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/16\/5201\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:30:04Z","timestamp":1760128204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/16\/5201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":40,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["jcm12165201"],"URL":"https:\/\/doi.org\/10.3390\/jcm12165201","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}